GeneBio was established in 1997 by three eminent scientists, Ron Appel, Amos Bairoch and Denis Hochstrasser
, in parallel with the establishment of the Swiss Institute of Bioinformatics (SIB). GeneBio's commercial endeavors debuted in 1998 as we began to give commercial access via license to the Swiss-Prot database.
Since our inception, we have evolved from an initial and continuing mandate to commercialize databases and other products developed by the SIB into a truly global multifaceted bioinformatics company offering a spectrum of original solutions.
GeneBio's headquarters are in Geneva, Switzerland. In 2005 GeneBio opened a Japanese branch located in Tokyo, Japan.
Life Sciences have been continuously revolutionized both in the rate of data accumulation and in the diversity of the biological information being generated through a multitude of technologies. This industry has dramatically changed over the last 20 years; we are now more in a "knowledge-limited" rather than "information-limited" era. The industry is now confronted with the ever-growing problem of transforming these masses of heterogeneous information into integrated and structured knowledge.
To overcome this information bottleneck, we must concentrate on putting together the right information and tools in a contextualized manner in order to allow research scientists to easily corroborate those separate pieces of information, and thus to generate pertinent biological knowledge. At GeneBio we face this task head-on by producing software platforms that allow users to sift through reams of data, process it, compare it, and cross reference it, in order to give the data structure and meaning.
We focus our expertise on Mass Spectrometry characterization of proteins and small molecules as well as proteome imaging, offering clients and partners a high degree of specialization essential to their research. Close ties to academic peers and a thorough network of distribution and strategic partners give us both unfettered access to scientific excellence and recognized market presence so that we may best serve the scientific community.
Founders and Management
At GeneBio, we pride ourselves on our hand-picked team of scientific, commercial and administrative experts. By harnessing our mix of skills, experience and know-how, we are able to continuously meet the needs of our customers. With the added presence of our founders, all eminent scientists with a wide range of experience in Life Sciences, we perfect a winning team with the skills and resources required to maneuver the company towards ever-new horizons.
Prof. Ron D. Appel, Ph.D.
Ron Appel, Ph.D. in Computer Sciences from the University of Geneva, was co-founder of the SIB Swiss Institute of Bioinformatics in 1998. He led the Proteome Informatics Group pioneering the development of proteomics software and databases, in particular Melanie 2-D gel electrophoresis analysis sortware. Ron was also the initator of ExPASy, the world's first Web site dedicated to life sciences. Currently he is the Executive Director of SIB Swiss Institute of Bioinformatics and Professor of Bioinformatics at the University of Geneva.
Prof. Amos Bairoch, Ph.D.
Prof. Amos Bairoch, Ph.D. in Biochemistry, is professor and head of the Department of Structural Biology and Bioinformatics of Geneva University and a founder of the SIB Swiss Institute of Bioinformatics. Amos founded the world-renowned protein database Swiss-Prot (now integrated in the UniProt Knowledgebase ). He was also responsible for the development of the PC/Gene sequence analysis software package, as well as the PROSITE and ENZYME databases. He was also a co-creator of the ExPASy proteome analysis Web server and its protein characterization tools. Amos is now Head of CALIPHO, an interdisciplinary team of biocurators, bioinformaticians and experimentalists who are using different methodologies to help uncover the function of uncharacterized human proteins.
Prof. Denis F. Hochstrasser, M.D.
Prof. Denis F. Hochstrasser, M.D., is director of the Department of Genetic and Laboratory Medicine at Geneva University Hospital and Vice Dean of the Faculty of Medicine, University of Geneva. Denis is also Head of the Clinical Chemistry Laboratory of the Geneva University Hospital. He is full Professor both to Geneva University's Department of Structure Biology and Bioinformatics in the Medical School and to the School of Pharmacy in the Science Faculty. He is an authority on clinical proteomics and a pioneer in its application in the medical field.
Nasri Nahas, ME, MBA : Chief Executive Officer
Nasri has extensive experience and a proven track record in the development, implementation and management of key cross-functional operations and projects. Prior to joining GeneBio in 2001, Nasri held various scientific and business positions within the biotech industry, particularly with Genset SA and ValiGen SA in Paris. In his role as Chief Executive Officer, Nasri has complete responsibility of GeneBio's operations and will strengthen the company's leading position in knowledge-based bioinformatics, in particular in establishing and managing new business operations and partnerships. In addition to his MBA, Nasri holds an ME in Bio-Industry as well as a BSc in Biology and Medical Studies.